PHLDA3 exerts an antitumor function in prostate cancer by down-regulating Wnt/β-catenin pathway via inhibition of Akt.
Ma S, Quan P, Yu C, Fan X, Yang S, Jia W, Zhang L, Wang F, Liu F, Yang L, et al. Biochem Biophys Res Commun. 2021 Sep 24; 571:66-73. Epub 2021 Jul 22.